Ronaldo Supena
Infectious Disease · Detroit, MINPI 1275576886
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 683 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Viiv Healthcare Company at 43.2% of the total. Reporting peaked in 2023 at $2,800 and has fallen 53.2% since, to $1,310 in 2025. Among infectious disease clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 683 payments — averaging $21.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$6K
- Gilead$4K
- Merck$2K
- Janssen Products, LP$1K
- Johnson & Johnson$934
- Pfizer$176
- plus $342 from 13 others
What the payments were for
- Food & beverage$14,04397%
- Education$4503%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 348 | $6,260 |
| Gilead | 176 | $3,835 |
| Merck | 73 | $1,749 |
| Janssen Products, LP | 11 | $1,197 |
| Johnson & Johnson(2 entities) | 51 | $934 |
| Pfizer | 5 | $176 |
| Stryker | 1 | $44 |
| Biohaven Pharmaceuticals, Inc. | 3 | $43 |
| Napo Pharmaceuticals Inc | 2 | $41 |
| Exact Sciences | 2 | $37 |
| GSK | 2 | $27 |
| Modernatx, Inc. | 1 | $24 |
| EMD Serono, Inc. | 2 | $22 |
| Vyera Pharmaceuticals, LLC | 1 | $22 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Phadia US Inc. | 1 | $20 |
| Qiagen, LLC | 1 | $15 |
| Theratechnologies Inc. | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,493 in reported general payments places this provider in the 90th percentile of 257 infectious disease providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 84 | $337,837 |
| JulucaDolutegravir/Rilpivirine | 57 | $190,721 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 41 | $170,799 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 35 | $156,778 |
| CabenuvaCabotegravir/Rilpivirine | 14 | $95,576 |
| DovatoDolutegravir Sodium/Lamivudine | 33 | $95,267 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 20 | $76,637 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 17 | $58,844 |
| DelstrigoDoravirine/Lamivu/Tenofov Diso | 15 | $42,089 |
| TivicayDolutegravir Sodium | 16 | $35,185 |
| PrezcobixDarunavir/Cobicistat | 14 | $33,133 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 35 | $932 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $889 |
| Ventolin HfaAlbuterol Sulfate | 15 | $788 |
| Pravastatin Sodium | 94 | $566 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya | $3,835 | $508,637125 claims |
| Viiv Healthcare CompanyJuluca, Cabenuva, Dovato, Triumeq, Tivicay | $6,260 | $475,592137 claims |
| Janssen Products, LPSymtuza | $1,197 | $156,77835 claims |
| MerckDelstrigo | $1,749 | $42,08915 claims |
| Johnson & JohnsonPrezcobix | $934 | $33,13314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 257 infectious disease providers in Michigan.
Other infectious disease in Detroit
- Teena ChopraDetroit$328K
- Indira BrarDetroit$323K
- Rodger MacarthurDetroit$150K
- Pranatharthi ChandrasekarDetroit$71K
- Mayur RameshDetroit$30K
- Marcus ZervosDetroit$26K
- Jack SobelDetroit$18K
- Smitha GudipatiDetroit$16K
- Wasif HafeezDetroit$5K
- Nicholas YaredDetroit$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.